Table of exposure limits for chemical and biological substances Updated 2024/04/11

Occupational Health and Safety Regulation section 5.48 provides established exposure limits for a worker's exposure to hazardous
chemical substances. Generally, these exposure limits are established according to the Threshold Limit Values ("TLVs") adopted by the
American Conference of Governmental Industrial Hygienists ("ACGIH"). WorkSafeBC (the Workers’ Compensation Board) has the
authority to make exceptions and adopt exposure limits for specific chemical substances that are not consistent with the TLVs established
by the ACGIH. Policy R5.48-1 sets out those exceptions. The below Table of Exposure Limits for Chemical and Biological Substances
shows all exposure limits for British Columbia workplaces, i.e., adopted TLVs and exposure limits developed by exception.

WorkSafeBC publishes this exposure limit table in accordance with its mandate under the Workers Compensation Act to provide
information and promote public awareness. This table does not represent the official exposure limits and designations. WorkSafeBC does
not warrant the accuracy or the completeness of the information in this table, and none of its board of directors, employees or agents shall
be liable to any person for any loss or damage of any nature arising from this version.

Where WorkSafeBC has adopted a TLV or ACGIH designation, the official exposure limit is in the ACGIH TLV documentation. Where
an exposure limit is adopted by exception, the official exposure limit is found in Policy R5.48-1. The official source of the International
Agency for Research on Cancer (IARC) carcinogenicity designations is the IARC set of monographs.

Explanation of table entries

General notes regarding the Table entries.
•         Chemicals and other substances are listed in alphabetical order. Numerals and prefixes, for example, 1,3-, tert-, o-,
sec-, cis-, are disregarded in determining alphabetical order.
•         In square brackets is the Chemical Abstracts Services (CAS) registry number. This is a unique identification number assigned
specifically to that substance, and can be a convenient way to identify substances.
•        WorkSafeBC reviews and updates this Table as necessary. If the exposure limit for a substance has been revised or newly adopted
since January 1, 2003 this Table reports the change with the words "Revised (year)". Each year, new and amended substances, including
notation changes, are highlighted for a period of time in the Table. Recent deletions of substances from the Table are shown as strike
through (e.g., Emery).
•         Endnotes: Letters in parentheses indicate endnotes, which are explained at the end of the table. Substances which have an "L"
endnote are subject to section 5.57 (Designated substances) of the OHS Regulation . For more information see OHS Guideline G5.57.
•         For solid and liquid particulate matter, except where the terms inhalable, thoracic, or respirable particulate mass are stated, the
exposure limits listed in the table are expressed in terms of "total particulate matter".
• Additional explanation about this table is available at G5.48-2 Annual revisions to exposure limits

TWA column
This is the 8-hour time weighted average (TWA) limit, as defined in section 5.1 of the OHS Regulation.
•         Units: Exposure limits are reported in ppm, mg/m3, or f/cc. In general, substances present in air as a vapour or gas are reported in
parts per million (ppm). Substances present in air as an aerosol (dust, fume, mist) and mixtures such as diesel fuel are typically reported in
milligrams per cubic metre (mg/m3). See OHS Guideline G5.48-4 for a procedure to convert from one type of unit to the other. Fibrous
substances, such as synthetic vitreous fibres (e.g., glass wool fibres) are reported in fibres per cubic centimetre (f/cc). This is equivalent to
fibres per millilitre, or f/ml, which is another common term.

STEL/Ceiling column
This is the short-term exposure limit or STEL, which is defined in section 5.1 of the OHS Regulation . Note that:
•      "C" indicates a ceiling limit, which is defined in section 5.1 of the OHS Regulation.
•         The units ppm and mg/m3 are used as in the TWA column.
•         In some cases, the term "simple asphyxiant" is used. This is a gas or vapour that can displace oxygen in the air, resulting in possible
suffocation from lack of oxygen. Because simple asphyxiants do not have other significant toxic effects, an exposure limit is not
applicable. The limiting factor is the available oxygen. See section 5.56 of the OHS Regulation (Oxygen deficiency).

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 1 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Notations column
The notations identify substances considered to be carcinogens, sensitizers and those with adverse reproductive effect under section 5.57
of the OHS Regulation . Section 5.57 deals with requirements for substitution and keeping exposure as low as reasonably achievable
below the exposure limit. The notations column also indicates substances that contribute significantly to overall exposure by the skin
route, in which case section 5.52 of the OHS Regulation applies. Note that:
•         ACGIH notations A1 and A2 and IARC notations 1, 2A and 2B indicate substances designated as carcinogens under section 5.57(1)
of the OHS Regulation . The different categories used by the two organizations indicate different levels of certainty of carcinogenic effect,
eg. from confirmed carcinogen to probable or possible. For more information see OHS Guideline G5.57.
•         Three terms, "S", "S(D)", and "S(R)", indicate a substance is an ACGIH sensitizer under section 5.57(1) of the OHS Regulation. The
ACGIH indicates that a substance is a sensitizer with a "SEN" notation or it states a substance as having a sensitizing effect in the TLV
Basis column in the ACGIH booklet. "S" indicates that a substance has the potential to produce sensitization, as confirmed by human or
animal data. "S(D)" indicates a substance with specific evidence of sensitization by dermal route and "S(R)" indicates a substance with
specific evidence of sensitization by respiratory route. The absence of a sensitization notation does not mean that a substance lacks the
ability to produce sensitization, but may reflect the inconclusiveness of scientific evidence. For more information, see OHS Guideline
G5.57.
•         The letter "R" means that the substance has an adverse reproductive effect under section 5.57(1) of the OHS Regulation. For more
information see OHS Guideline G5.57.
• The term "EX" means that the substance is a flammable asphyxiant or excursions above the exposure limit could approach 10% of
the lower explosive limit.
•         The term "Skin" identifies substances that contribute significantly to the overall exposure by the skin route. For more information see
OHS Guideline G5.52.
Substance [CAS No.] TWA STEL/Ceiling Notations
Abate (See Temephos)
Acetaldehyde [75-07-0] Revised 2014 C 25 ppm A2, 2B
Acetamide [60-35-5] 2B; (I)
Acetamiprid, Inhalable fraction and vapour [135410-20-7] R; (I)
Acetic acid [64-19-7] 10 ppm 15 ppm
Acetic anhydride [108-24-7] Revised 2011 1 ppm 3 ppm
Acetone [67-64-1] 250 ppm 500 ppm
Acetone cyanohydrin, as CN [75-86-5] C 1ppm Skin
Acetonitrile [75-05-8] 20 ppm Skin
Acetophenone [98-86-2] 10 ppm R
Acetylene [74-86-2] Simple EX
asphyxiant
Acetylene tetrabromide (See 1,1,2,2 Tetrabromoethane)
Acetylsalicylic acid (Aspirin) [50-78-2] 5 mg/m3 S(R); Skin
Acrolein [107-02-8] C 0.1 ppm Skin; 2A
Acrylamide, Inhalable [79-06-1] Revised 2005 0.03 mg/m (V) 3 S(D); Skin; A2; 2A
Acrylic acid [79-10-7] 2 ppm Skin; R
Acrylonitrile [107-13-1] 2 ppm Skin; 2B
Adipic acid [124-04-9] 5 mg/m3
Adiponitrile [111-69-3] 2 ppm Skin
Alachlor, Inhalable [15972-60-8] Revised 2007 3
1.0 mg/m (V) S(D)
Aldicarb [116-06-3] Skin; (I)
Aldrin, Inhalable [309-00-2] Revised 2007 0.05mg/m3 (V) 2A; Skin
Allyl alcohol [107-18-6] 0.5 ppm Skin
Allyl amine [107-11-9] 2 ppm
Allyl bromide [106-95-6] Skin; (I)
Allyl chloride [107-05-1] Revised 2011 1 ppm 2 ppm Skin
Allyl glycidyl ether [106-92-3] 1 ppm
Allyl methacrylate [96-05-9] Skin; (I)
Allyl propyl disulfide [2179-59-1] Revised 2006 0.5 ppm S(D)

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 2 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Aluminum metal and insoluble compounds [7429-90-5] , Respirable, Revised 1.0 mg/m3
2008
o-Aminoazotoluene [97-56-3] 2B
4-Aminobiphenyl [92-67-1] (L) Skin; A1, 1
1-Amino-2,4-dibromoanthraquinone [81-49-2] 2B
2-Aminopyridine [504-29-0] 0.5 ppm
Amitrole [61-82-5] Revised 2006 0.2 mg/m3 R
Ammonia [7664-41-7] 25 ppm 35 ppm
Ammonium chloride - Fume [12125-02-9] 10 mg/m3 20 mg/m3
Ammonium perfluorooctanoate [3825-26-1] 0.01 mg/m3 Skin
Ammonium sulfamate [7773-06-0] 10 mg/m3 (N)
tert-Amyl methyl ether (TAME) [994-05-8] 20 ppm R
Aniline [62-53-3] 2 ppm Skin; 2A
o-Anisidine [90-04-0] 0.5 mg/m3 Skin; 2A
p-Anisidine [104-94-9] 0.5 mg/m3 Skin
Anthraquinone [84-65-1] 2B
Antimony and compounds, as Sb [7440-36-0] 0.5 mg/m3
Antimony hydride (Stibine) [7803-52-3] 0.1 ppm
Antimony trioxide, Inhalable [1309-64-4] A2, 2B, (I)
Antimony trioxide - Production [1309-64-4] (L) A2, 2B
ANTU [86-88-4] 0.3 mg/m3 Skin
Argon [7440-37-1] Simple
asphyxiant
Arsenic and inorganic compounds, as As [7440-38-2] 0.01 mg/m3 A1, 1
Arsine [7784-42-1] Revised 2007 0.005 ppm
Asbestos - All forms [1332-21-4] 0.1 f/cc (F) A1, 1
Asphalt (Bitumen) fume, as benzene-soluble aerosol, Inhalable 0.5 mg/m 3 2B, (I)
[8052-42-4]
Atrazine [1912-24-9] 5 mg/m3 R
Azinphos-methyl, Inhalable [86-50-0] 0.2 mg/m3 (V) Skin; S(D)
Barium and soluble compounds, as Ba [7440-39-3] 0.5 mg/m3
Barium sulfate [7727-43-7], Inhalable, Revised 2018 5 mg/m3 (E)
Bendiocarb [22781-23-3] Skin; (I)
Benomyl, Inhalable [17804-35-2] Revised 2008 1 mg/m3 R, S(D)
Bensulide, Inhalable fraction and vapour [741-58-2] (I)
Benz[a]anthracene [56-55-3] Revised 2006 (L) A2, 2B
Benzene [71-43-2] 0.5 ppm 2.5 ppm Skin; A1, 1
Benzidine [92-87-5] (L) Skin; A1, 1
Benzidine based dyes 2A
Benzo[b]fluoranthene [205-99-2] (L) A2, 2B
Benzoic acid and alkali benzoates:
Benzoic acid [65-85-0], Inhalable fraction and vapour Skin; (I)
Sodium benzoate, as benzoate [532-32-1], Inhalable Skin; (I)
Potassium benzoate, as benzoate [582-25-2], Inhalable Skin; (I)
Benzophenone [119-61-9] 2B
Benzo[a]pyrene [50-32-8] Revised 2006 (L) A2, 1
1,4-Benzoquinone [106-51-4] 0.1 ppm S(D)
Benzotrichloride [98-07-7] C 0.1 ppm Skin; A2, 2A
Benzoyl chloride [98-88-4] C 0.5 ppm 2A
Benzoyl peroxide [94-36-0] 5 mg/m3
Benzyl acetate [140-11-4] 10 ppm
Benzyl chloride [100-44-7] C 1 ppm 2A
Beryllium and compounds, Inhalable, as Be [7440-41-7] Revised 2009; 2010; A1, 1; Skin; S(D);
2015 0.00005 mg/m3 S(R); (I)

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 3 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Biphenyl [92-52-4] 0.2 ppm
Bismuth telluride - Se-doped [1304-82-1] 5 mg/m3
Bismuth telluride - Undoped [1304-82-1] 10 mg/m3 (N)
Borate compounds, Inorganic, Inhalable [1303-96-4; 1330-43-4; 10043-35-3; 2 mg/m3 6 mg/m3
12179-04-3] Revised 2005
Boron oxide [1303-86-2] 10 mg/m3
Boron tribromide [10294-33-4] C 1 ppm
Boron trichloride [10294-34-5] (I)
Boron trifluoride [7637-07-2] Revised 2020 0.1 ppm C 1 ppm
Boron trifluoride ethers, as BF3 [109-63-7; 353-42-4] 0.1 ppm
Bromacil [314-40-9] 10 mg/m3
Bromine [7726-95-6] 0.1 ppm 0.2 ppm
Bromine pentafluoride [7789-30-2] 0.1 ppm
Bromochloroacetic acid [5589-96-8] 2B
Bromochloromethane [74-97-5] 200 ppm 250 ppm
Bromodichloromethane [75-27-4] 2B
Bromoform [75-25-2] Revised 2009 0.5 ppm
1-Bromopropane [106-94-5] Revised 2018 0.1 ppm R; 2B
Buprofezin, Inhalable fraction and vapour [69327-76-0] S(D); (I)
1,3-Butadiene [106-99-0] 2 ppm A2, 1
Butane, all isomers: n-butane [106-97-8] and isobutane [75-28-5] Revised 2018 1000 ppm EX
n-Butanol [71-36-3] 15 ppm C 30 ppm
sec-Butanol [78-92-2] 100 ppm
tert-Butanol [75-65-0] 100 ppm
Butenes, all isomers, including Isobutene [106-98-9; 107-01-7; (I)
590-18-1; 624-64-6; 25167-67-3; 115-11-7]
2-Butoxyethanol (EGBE) [111-76-2] Revised 2003 20 ppm
2-Butoxyethyl acetate [112-07-2] Revised 2003 20 ppm
1-tert-Butoxypropan-2-ol 2B
Butyl acetate, all isomers [105-46-4; 110-19-0; 123-86-4; 540-88-5] 50 ppm 150 ppm
n-Butyl acrylate [141-32-2] 2 ppm S(D)
n-Butylamine [109-73-9] C 5 ppm Skin
Butylated hydroxytoluene (BHT), Inhalable, (2,6-Di-tert-butyl-p-cresol) [128-37-0] 2 mg/m3 (V)
tert-Butyl chromate, as CrO3 [1189-85-1] C 0.1 mg/m3 Skin
n-Butyl glycidyl ether (BGE) [2426-08-6] Revised 2005 3 ppm 2B; Skin; S(D); R
tert-Butyl hydroperoxide [75-91-2] A2; (I)
n-Butyl lactate [138-22-7] 5 ppm
n-Butyl mercaptan [109-79-5] 0.5 ppm
n-Butyl methacrylate [97-88-1] 50 ppm
4-tert-Butylbenzoic acid [98-73-7] (I); Skin; R
o-sec-Butylphenol [89-72-5] 5 ppm Skin
p-tert-Butyltoluene [98-51-1] 1 ppm
Cadmium and compounds, as Cd [7440-43-9] 0.01 mg/m3 A2, 1
Cadmium and compounds, Respirable, as Cd [7440-43-9] 0.002 mg/m3 A2, 1
Cadusafos [95465-99-9] Skin; (I)
Calcium carbonate (incl. Limestone, Marble) [1317-65-3] 10 mg/m3 (N) 20 mg/m3
Calcium chromate, as Cr, Total [13765-19-0] 0.001 mg/m3 A1, 1; Skin; S(D);
S(R)
Calcium cyanamide [156-62-7] 0.5 mg/m3
Calcium hydroxide [1305-62-0] 5 mg/m3
Calcium oxide [1305-78-8] 2 mg/m3
Calcium silicate, naturally occurring as Wollastonite, Inhalable [13983-17-0] 1 mg/m3 (E)
Revised 2020

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 4 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Calcium sulfate, Inhalable [7778-18-9; 10034-76-1; 10101-41-4; 13397-24-5] 10 mg/m3
Camphor - Synthetic [76-22-2] 2 ppm 3 ppm
Caprolactam, Dust [105-60-2] 1 mg/m3 3 mg/m3
Captafol [2425-06-1] 0.1 mg/m3 Skin; 2A; S(D);S(R)
Captafol, Inhalable fraction and vapour [2425-06-1] 2A; S(D);S(R) (I)
Captan, Inhalable [133-06-2] 5 mg/m3 S(D)
Carbaryl [63-25-2] Revised 2008; 2010 5 mg/m3 Skin; R
Carbazole [86-74-8] 2B
Carbofuran, Inhalable [1563-66-2] Revised 2004 0.1 mg/m3 (V)
Carbon black, Inhalable [1333-86-4] Revised 2011 3 mg/m3 2B
Carbon dioxide [124-38-9] 5000 ppm 15,000 ppm
Carbon disulfide [75-15-0] 4 ppm 12 ppm Skin
Carbon monoxide [630-08-0] 25 ppm 100 ppm R
Carbon tetrabromide [558-13-4] 0.1 ppm 0.3 ppm
Carbon tetrachloride [56-23-5] 2 ppm Skin; A2, 2B
Carbonyl fluoride [353-50-4] 2 ppm 5 ppm
Carbonyl sulfide [463-58-1] Revised 2015 5 ppm
Carfentrazone-ethyl [128639-02-1] (I)
Catechol [120-80-9] 5 ppm Skin; 2B
Cellulose [9004-34-6] 10 mg/m3 (N)
Cesium hydroxide [21351-79-1] 2 mg/m3
Chlordane [57-74-9] 0.5 mg/m3 Skin; 2B
Chlordane, Inhalable fraction and vapour [57-74-9] Skin; 2B; (I)
Chlorinated camphene [8001-35-2] 0.5 mg/m3 1 mg/m3 Skin; 2B
o-Chlorinated diphenyl oxide [31242-93-0] 0.5 mg/m3
Chlorine [7782-50-5] 0.1 ppm 1 ppm
Chlorine dioxide [10049-04-4] 0.1ppm 0.3 ppm
Chlorine trifluoride [7790-91-2] C 0.1 ppm
Chloroacetaldehyde [107-20-0] C 1 ppm
Chloroacetic acid (monochloroacetic acid) [79-11-8] 0.3 ppm Skin
Chloroacetone [78-95-5] C 1 ppm Skin
2-Chloroacetophenone [532-27-4] 0.05 ppm
Chloroacetyl chloride [79-04-9] 0.05 ppm 0.15 ppm Skin
p-Chloroaniline [106-47-8] 2B
Chlorobenzene [108-90-7] 10 ppm
o-Chlorobenzylidene malononitrile [2698-41-1] C 0.05 ppm Skin
Chlorobromomethane (see Bromochloromethane)
Chlordecone (Kepone) [143-50-0] 2B
1-Chloro-1,1-difluoroethane [75-68-3] 1000 ppm
Chlorodifluoromethane [75-45-6] 500 ppm 1250 ppm
Chlorodiphenyl (42% chloride) [53469-21-9] 1 mg/m 3 Skin; 1
Chlorodiphenyl (54% chloride) [11097-69-1] 0.5 mg/m3 Skin; 1
Chloroform [67-66-3] 2 ppm 2B; R
bis(Chloromethyl) ether [542-88-1] 0.001 ppm A1, 1
Chloromethyl methyl ether [107-30-2] (L) A2, 1
1-Chloro-2-methylpropene [513-37-1] 2B
3-Chloro-2-methylpropene [563-47-3] 2B
1-Chloro-1-nitropropane [600-25-9] 2 ppm
Chloropentafluoroethane [76-15-3] 1000 ppm
4-Chloro-ortho-phenylenediamine [95-83-0] 2B
Chloropicrin [76-06-2] 0.1 ppm
beta-Chloroprene [126-99-8] 10 ppm A2; 2B; Skin

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 5 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

1-Chloro-2-propanol [127-00-4] Revised 2008 1 ppm Skin
2-Chloro-1-propanol [78-89-7] Revised 2008 1 ppm Skin
2-Chloropropionic acid [598-78-7] 0.1 ppm Skin; R
o-Chlorostyrene [2039-87-4] 50 ppm 75 ppm
Chlorothalonil [1897-45-6] 2B
o-Chlorotoluene [95-49-8] 50 ppm
4-Chloro-o-Toluidine [95-69-2] 2A
Chlorotrifluoromethane [75-72-9] 1000 ppm
Chlorpyrifos, Inhalable [2921-88-2] Revised 2003 0.1 mg/m3 (V) Skin
Chromium and inorganic compounds:
Metallic chromium, as Cr(0), Total [7440-47-3] 0.5 mg/m3
Metallic chromium, as Cr(0), Inhalable [7440-47-3] (I)
Trivalent chromium compounds, as Cr (III), Total [7440-47-3] 0.5 mg/m3 S(D), S(R) for water
soluble only
Trivalent chromium compounds, as Cr(III), Inhalable [7440-47-3] S(D), S(R) for water-
soluble only; (I)
Hexavalent chromium compounds, as Cr(VI), Total, Insoluble [7440-47-3] 0.01 mg/m3 A1, 1; S(D); S(R)
Hexavalent chromium compounds, as Cr(VI), Total, Water-soluble 0.025 mg/m3 C 0.1 mg/m3 A1, 1; Skin; S(D);
[7440-47-3] S(R)
Hexavalent chromium compounds, as Cr(VI), Inhalable [7440-47-3] A1, 1; S(D); S(R);
Skin for water-
Chromyl chloride, as Cr(VI), Total [14977-61-8] 0.025 ppm A1, 1; Skin; S(D);
S(R)
Chromite ore processing (See Trivalent chromium compounds, as Cr(III), A1, 1; Skin; S(D);
Total; and Hexavalent chromium compounds, as Cr(VI), Total) S(R)
Chrysene [218-01-9] Revised 2006 (L) 2B
Citral, inhalable [5292-40-5] Skin; S(D); (I)
Clopidol [2971-90-6] Revised 2018 10 mg/m3
Clothianidin [210880-92-5], Inhalable (I); R
Coal dust - Anthracite, Respirable [8029-10-5] 0.4 mg/m 3

Coal dust - Bituminous or Lignite, Respirable [308062-82-0] 0.9 mg/m3

Coal tar pitch volatiles, as benzene-soluble aerosol [65996-93-2] 0.2 mg/m3 A1, 1
Cobalt and inorganic compounds, as Co, Total [7440-48-4] 0.02 mg/m3 2B; S(D); S(R)
Cobalt and inorganic compounds, as Co, Inhalable [7440-48-4] 2B, S(D); S(R);(I)
Cobalt carbonyl, as Co [10210-68-1] 0.1 mg/m3 2B
Cobalt hydrocarbonyl, as Co [16842-03-8] 0.1 mg/m3 2B
Copper - Dusts and mists, as Cu [7440-50-8] 1 mg/m3
Copper - Fume, as Cu [7440-50-8] 0.2 mg/m3
Cotton dust - Raw, Untreated, Thoracic, Revised 2011 0.1 mg/m3
Coumaphos, Inhalable [56-72-4] Revised 2006 0.05 mg/m3 (V) Skin
p-Cresidine [120-71-8] 2B
Cresol, all isomers [95-48-7; 106-44-5; 108-39-4; 1319-77-3] 10 mg/m3 Skin
Crotonaldehyde [4170-30-3] C 0.3 ppm Skin; 2B
Crufomate [299-86-5] 5 mg/m 3

Cumene [98-82-8] 25 ppm 75 ppm 2B

Cyanamide [420-04-2] 2 mg/m3
Cyanazine [21725-46-2] (I); R
Cyanoacrylates, Ethyl [7085-85-0] and Methyl [137-05-3] 0.2 ppm S(D); S(R)
Cyanogen [460-19-5] 10 ppm
Cyanogen bromide [506-68-3] (I)
Cyanogen chloride [506-77-4] C 0.3 ppm
Cyclohexane [110-82-7] 100 ppm
Cyclohexanol [108-93-0] 50 ppm Skin

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 6 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Cyclohexanone [108-94-1] Revised 2003 20 ppm 50 ppm Skin
Cyclohexene [110-83-8] Revised 2023 20 ppm
Cyclohexylamine [108-91-8] 10 ppm
Cyclonite [121-82-4] 0.5 mg/m3 Skin
Cyclopentadiene [542-92-7] 75 ppm
Cyclopentane [287-92-3] 600 ppm EX
Cyhexatin [13121-70-5] 5 mg/m 3

Cyromazine [66215-27-8], Inhalable (I)

2,4-D (2,4-Dichlorophenoxy-acetic acid) [94-75-7] (see 2,4-Dichlorophenoxyacetic
acid and its esters)
DDT (Dichloro-diphenyltrichloroethane) [50-29-3] 1 mg/m3 2A
Decaborane [17702-41-9] 0.05 ppm 0.15 ppm Skin
Demeton, Inhalable [8065-48-3] 0.05 mg/m3 (V) Skin
Demeton-S-methyl, Inhalable [919-86-8] 0.05 mg/m3 (V) Skin; S(D)
Diacetone alcohol [123-42-2] 50 ppm
Diacetyl [431-03-8] Revised 2015 0.01 ppm 0.02 ppm S(D)
N,N'-Diacetylbenzidine [613-35-4] 2B
2,4-Diaminoanisole [615-05-4] 2B
4,4'-Diaminodiphenyl ether [101-80-4] 2B
2,4-Diaminotoluene [95-80-7] 2B
o-Dianisidine [119-93-7] 2B
Diazinon, Inhalable [333-41-5] Revised 2003 0.01 mg/m3 (V) 2A; Skin
Diazomethane [334-88-3] 0.2 ppm A2
Diborane [19287-45-7] 0.1 ppm
Dibromoacetic acid [631-64-1] 2B
Dibromoacetonitrile [3252-43-5] 2B
1,2-Dibromo-3-chloropropane [96-12-8] 2B
2,3-Dibromopropan-1-ol [96-13-9] 2B
2-N-Dibutylaminoethanol [102-81-8] 0.5 ppm Skin
Dibutyl phenyl phosphate [2528-36-1] 0.3 ppm Skin
Dibutyl phosphate [107-66-4] Revised 2009; 2010 1 ppm 2 ppm Skin
Dibutyl phthalate [84-74-2] 5 mg/m3 R
Dichloroacetic acid [79-43-6] Revised 2005 0.5 ppm Skin; 2B; R
Dichloroacetylene [7572-29-4] C 0.1 ppm
o-Dichlorobenzene [95-50-1] 25 ppm 50 ppm
p-Dichlorobenzene [106-46-7] 10 ppm 2B
3,3'-Dichlorobenzidine [91-94-1] (L) Skin; 2B
1,4-Dichloro-2-butene [764-41-0] 0.005 ppm Skin; A2
2,2-Dichlorodiethyl sulfide (Mustard Gas) [505-60-2] 1
Dichlorodifluoromethane [75-71-8] 1000 ppm
1,3-Dichloro-5,5-dimethylhydantoin [118-52-5] 0.2 mg/m3 0.4 mg/m3
1,1-Dichloroethane [75-34-3] 100 ppm
1,2-Dichloroethane (see ethylene dichloride)
1,2-Dichloroethylene, all isomers [540-59-0; 156-59-2; 156-60-5] 200 ppm
Dichloroethyl ether [111-44-4] 5 ppm 10 ppm Skin
Dichlorofluoromethane [75-43-4] 10 ppm
Dichloromethane [75-09-2] 25 ppm 2A
2,2'-Dichloro-n-methyldiethylamine (Nitrogen mustard) [51-75-2] 2A
1,1-Dichloro-1-nitroethane [594-72-9] 2 ppm
1,3-Dichloro-2-propanol [96-23-1] 2B
1,3-Dichloropropene [542-75-6] 1 ppm Skin; 2B
2,4-Dichlorophenoxyacetic acid and its esters (2,4-D) [94-75-7] Revised 2006 10 mg/m3 20 mg/m3 2B; (I)
2,2-Dichloropropionic acid, Inhalable [75-99-0] 5 mg/m3
Bracketed letters are end notes, e.g., "(L)" and "(V)";
STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 7 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Dichlorotetrafluoroethane (Cryofluorane) [76-14-2] 1000 ppm
Dichlorvos (DDVP), Inhalable [62-73-7] 0.1 mg/m3 (V) Skin; 2B; S(D)
Dicrotophos, Inhalable [141-66-2] 0.05 mg/m3 (V) Skin
Dicyclohexylmethane-4,4'-diisocyanate [5124-30-1] (see Methylene bis (4-
cyclohexylisocyanate))
Dicyclopentadiene [77-73-6] 5 ppm
Dicyclopentadienyl iron, as Fe [102-54-5] 10 mg/m3 (N)
Dieldrin [60-57-1] 0.25 mg/m3 2A; Skin; R
Diesel fuel, as total hydrocarbons, Inhalable [68334-30-5; 100 mg/m3 (V) Skin; 2B; (I)
68476-30-2; 68476-31-3; 68476-34-6; 77650-28-3]
Diethanolamine [111-42-2] Revised 2009; 2010 2 mg/m3 Skin; 2B
Diethylamine [109-89-7] 5 ppm 15 ppm Skin
2-Diethylaminoethanol [100-37-8] 2 ppm Skin
Diethylene glycol monobutyl ether [112-34-5] (I)
Diethylenetriamine [111-40-0] 1 ppm Skin
Di(2-ethylhexyl)phthalate (DEHP) [117-81-7] 5 mg/m3 2B; Skin; R
N,N-Diethylhydroxylamine [3710-84-7] (I)
Diethyl ketone [96-22-0] 200 ppm 300 ppm
Diethyl phthalate [84-66-2] 5 mg/m3
Diethyl sulfate [64-67-5] 2A
Difluorodibromomethane [75-61-6] 100 ppm
Diglycidyl ether (DGE) [2238-07-5] Revised 2007 0.01 ppm R
Diglycidyl resorcinol ether [101-90-6] 2B
Dihydrosafrole [94-58-6] 2B
Diisobutyl ketone [108-83-8] 25 ppm
Diisocyanates, not elsewhere specified, NOS 0.005 ppm C 0.01ppm
Diisopropylamine [108-18-9] 5 ppm Skin
Diisopropyl sulfate [2973-10-6] 2B
3,3'-Dimethoxybenzidine [119-90-4] 2B
Dimethoxymethane [109-87-5] 1000 ppm 1250 ppm
Dimethylacetamide or N,N-Dimethylacetamide [127-19-5] 10 ppm 2B; Skin; R
Dimethylamine [124-40-3] 5 ppm 15 ppm S(D)
bis(2-Dimethylaminoethyl) ether (DMAEE) [3033-62-3] 0.05 ppm 0.15 ppm Skin
2,6-Dimethylaniline (2,6-Xylidine) [87-62-7] 2B
Dimethylaniline [121-69-7] 5 ppm 10 ppm Skin
3,3'-Dimethylbenzidine [119-93-7] 2B
Dimethyl carbamoyl chloride [79-44-7] Revised 2007 0.005 ppm Skin; A2, 2A
Dimethyl disulfide [624-92-0] Revised 2007 0.5 ppm Skin
Dimethyl ether [115-10-6] 1000 ppm
Dimethylethoxysilane [14857-34-2] 0.5 ppm 1.5 ppm
Dimethylformamide [68-12-2] 5 ppm Skin; 2A
1,1-Dimethylhydrazine [57-14-7] 0.01 ppm Skin; 2B
1,2-Dimethylhydrazine [540-73-8] 2A
Dimethylphenol, all isomers [95-65-8; 95-87-4; 105-67-9; 108-68-9; 526-75-0; 576-
26-1; 1300-71-6] S(D), (I)
Dimethyl phthalate [131-11-3] 5 mg/m3
Dimethyl sulfate [77-78-1] C 0.1 ppm Skin; 2A
Dimethyl sulfide [75-18-3] Revised 2004 10 ppm
N,N-Dimethyl-p-toluidine [99-97-8] 2B
Dinitolmide [148-01-6] (See 3,5-Dinitro-o-toluamide)
Dinitrobenzene, all isomers [99-65-0; 100-25-4; 528-29-0; 25154-54-5] 0.15 ppm Skin
Dinitro-o-cresol [534-52-1] 0.2 mg/m3 Skin
3,5-Dinitro-o-toluamide [148-01-6] Revised 2007 1 mg/m3

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 8 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Dinitrotoluene [25321-14-6] 0.2 mg/m3 Skin; 2B; R; (I)
n-Dioctyl phthalate [117-84-0] 5 mg/m3
1,4-Dioxane [123-91-1] 20 ppm Skin; 2B
Dioxathion, Inhalable [78-34-2] 0.1 mg/m3 (V) Skin
1,3-Dioxolane [646-06-0] 20 ppm
Diphenylamine [122-39-4] 10 mg/m3
Dipropyl ketone [123-19-3] 50 ppm
Dipropylene glycol methyl ether (DPGME) [13429-07-7; 13588-28-8; 20324-32-7; 100 ppm 150 ppm
34590-94-8; 55956-21-3]
Diquat, Inhalable, as the cation [85-00-7; 2764-72-9; 6385-62-2] 0.5 mg/m3 Skin
Diquat, Respirable, as the cation [85-00-7; 2764-72-9; 6385-62-2] 0.1 mg/m3 Skin
Disulfiram [97-77-8] 2 mg/m3
Disulfoton, Inhalable [298-04-4] 0.05 mg/m3 (V) Skin
Diuron [330-54-1] 10 mg/m3
Divinylbenzene [1321-74-0] 10 ppm
Divinylbenzene-ethyl styrene mixtures, as total divinylbenzene isomers [69011-19- S(D); (I)
4; 7525-62-4; 108-57-6; 105-06-6]
Dodecyl mercaptan [112-55-0] Revised 2004 0.1 ppm S(D)
Dyfonate, Inhalable (Fonofos) [944-22-9] Revised 2006 0.1 mg/m3 (V) Skin
Endosulfan [115-29-7] Revised 2009; 2010 0.1 mg/m3 Skin
Endrin [72-20-8] 0.1 mg/m3 Skin
Enflurane [13838-16-9] 2 ppm
Epichlorohydrin [106-89-8] 0.1 ppm 2A; A2; S(D); Skin; R

EPN, Inhalable [2104-64-5] Revised 2003 0.1 mg/m3 Skin

EPN, Inhalable fraction and vapour [2104-64-5] Skin, (I)
1,2-Epoxybutane [106-88-7] 2B
Ethane [74-84-0] Revised 2018 simple EX
Ethanol [64-17-5] Revised 2009 1000 ppm
Ethanolamine [141-43-5] 3 ppm 6 ppm
Ethion, Inhalable [563-12-2] Revised 2003 0.05 mg/m3(V) Skin
2-Ethoxyethanol (EGEE) [110-80-5] 5 ppm Skin; R
2-Ethoxyethyl acetate (EGEEA) [111-15-9] 5 ppm Skin; R
Ethyl acetate [141-78-6] 150 ppm
Ethyl acrylate [140-88-5] 5 ppm 15 ppm 2B; S(D)
Ethylamine [75-04-7] 5 ppm 15 ppm Skin
Ethyl amyl ketone [541-85-5] Revised 2007 10 ppm
Ethylbenzene [100-41-4] Revised 2011 20 ppm 2B
Ethyl bromide [74-96-4] 5 ppm Skin
Ethyl tert-butyl ether (ETBE) [637-92-3] Revised 2018 25 ppm
Ethyl butyl ketone [106-35-4] 50 ppm 75 ppm
Ethyl chloride [75-00-3] 100 ppm Skin
Ethyl methacrylate [97-63-2] 50 ppm
Ethylene [74-85-1] Revised 2005 200 ppm
Ethylene chlorohydrin [107-07-3] C 1 ppm Skin
Ethylenediamine [107-15-3] 10 ppm Skin
Ethylene dibromide [106-93-4] 0.5 ppm Skin; 2A
Ethylene dichloride (1,2-dichloroethane) [107-06-2] 1 ppm 2 ppm 2B
Ethylene glycol, Inhalable, aerosol only [107-21-1] (I)
Ethylene glycol, Total , aerosol only [107-21-1] 10 mg/m3 20 mg/m3, C
100 mg/m3
Ethylene glycol - Vapour [107-21-1] C 50 ppm

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 9 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Ethylene glycol dimethyl ether [110-71-4] Skin; R; (I)
Ethylene glycol dinitrate (EGDN) [628-96-6] 0.05 ppm Skin
Ethylene oxide [75-21-8] 0.1 ppm 1 ppm A2, 1
Ethyleneimine [151-56-4] Revised 2009; 2010 0.5 ppm Skin; 2B
Ethyl ether [60-29-7] 400 ppm 500 ppm
Ethyl formate [109-94-4] Revised 2015 100 ppm
2-Ethylhexanoic acid, Inhalable [149-57-5] 5 mg/m3 (V) R
2-Ethyl-1-hexanol [104-76-7] (I)
Ethylidene norbornene [16219-75-3] C 5 ppm
Ethyl isocyanate [109-90-0] 0.02 ppm 0.06 ppm Skin; S(D); (I)
Ethyl mercaptan [75-08-1] 0.5 ppm
N-Ethylmorpholine [100-74-3] 5 ppm Skin
Ethyl silicate [78-10-4] 10 ppm
Fenamiphos, Inhalable [22224-92-6] Revised 2006 0.05 mg/m3 (V) Skin
Fenoxycarb, Inhalable [72490-01-8] (I)
Fensulfothion, Inhalable [115-90-2] Revised 2005 0.01 mg/m3 (V) Skin
Fentanyl [437-38-7] and Fentanyl Citrate, as Fentanyl, Inhalable [990-73-8] Skin; (I)
Fenthion, Inhalable [55-38-9] Revised 2006 0.05 mg/m3 (V) Skin
Ferbam, Inhalable [14484-64-1] Revised 2009 5 mg/m3
Ferrovanadium dust [12604-58-9] 1 mg/m3 3 mg/m3
Flour dust, Inhalable 0.5 mg/m3 S(R)
Fludioxonil [131341-86-1] (I)
Fluorides, as F 2.5 mg/m3
Fluorine [7782-41-4] 0.1 ppm
Fluorine, as F [7782-41-4] (I)
Fluroxene [406-90-6] 2 ppm
Folpet [133-07-3] S(D); (I)
Fonofos (see Dyfonate) [944-22-9]
Formaldehyde [50-00-0] Revised 2020 0.1 ppm 0.3 ppm A1, 1; S(D); S(R)
Formamide [75-12-7] 10 ppm Skin
Formic acid [64-18-6] 5 ppm 10 ppm
Furan [110-00-9] 2B
Furfural [98-01-1] Revised 2020 0.2 ppm Skin
Furfuryl alcohol [98-00-0] 5 ppm 10 ppm 2B; Skin
Gallium arsenide, Respirable [1303-00-0] Revised 2005 0.0003 mg/m 3 1
Gasoline [86290-81-5] 300 ppm 500 ppm 2B
Germanium tetrahydride [7782-65-2] 0.2 ppm
Glutaraldehyde, Activated & unactivated [111-30-8] C 0.05 ppm S(D); S(R)
Glycerin - mist, Total [56-81-5] 10 mg/m3
Glycerin - mist, Respirable [56-81-5] 3 mg/m3
Glycidol [556-52-5] 2 ppm 2A
Glycidyl methacrylate [106-91-2] A2; 2A; S(D); Skin;
(I)
Glyoxal, Inhalable [107-22-2] 0.1 mg/m3 (V) S(D)
Glyphosate [1071-83-6] 2A; (I)
Grain dust (oat, wheat, barley) 4 mg/m3
Graphite - All forms except graphite fibres, Respirable [7782-42-5] 2 mg/m3
Gypsum [13397-24-5] 10 mg/m3 (N) 20 mg/m3
Hafnium and compounds, as Hf [7440-58-6] 0.5 mg/m3
Halothane [151-67-7] 2 ppm R
Hard metals, containing Cobalt and Tungsten Carbide, as Co, Thoracic 0.005 mg/m3 A2; 2A; S(R); (I)
[7440-48-4; 12070-12-1]

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 10 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Helium [7440-59-7] Simple
asphyxiant
Heptachlor [76-44-8] 0.05 mg/m3 Skin; 2B
Heptachlor epoxide [1024-57-3] 0.05 mg/m3 Skin
Heptane, Isomers [108-08-7; 142-82-5; 565-59-3; 589-34-4; 590-35-2; 591-76-4] 400 ppm 500 ppm

Hexachlorobenzene (HCB) [118-74-1] 0.002 mg/m3 Skin; 2B

Hexachlorobutadiene [87-68-3] 0.02 ppm Skin
Hexachlorocyclopentadiene [77-47-4] 0.01 ppm
Hexachloroethane [67-72-1] 1 ppm Skin; 2B
Hexachloronaphthalene [1335-87-1] 0.2 mg/m 3 Skin
2,4-Hexadienal [142-83-6] 2B
Hexafluoroacetone [684-16-2] 0.1 ppm Skin; R
Hexafluoropropylene [116-15-4] Revised 2007 0.1 ppm
Hexahydrophthalic anhydride, all isomers, Inhalable C 0.005 mg/m3 S(R)
[85-42-7; 13149-00-3; 14166-21-3] Revised 2004 (V)
Hexamethylene diisocyanate (HDI) [822-06-0] 0.005 ppm C 0.01 ppm S(R)
Hexamethylenetetramine, Inhalable fraction and vapour [100-97-0] S(D); (I)
Hexamethyl phosphoramide [680-31-9] Skin; 2B
n-Hexane [110-54-3] 20 ppm Skin
Hexane, all isomers except n-Hexane [75-83-2; 79-29-8; 96-14-0; 107-83-5] 200pm
Hexane (Commercial, <54% n-Hexane) and the branched hexane isomers Skin (Commercial,
[various, including 64742-49-0; 64742-89-8; 75-83-2; 79-29-8; 96-14-0; 107-83-5] <54% n-Hexane
only); (I)
1,6-Hexanediamine [124-09-4] 0.5 ppm
Hexazinone [51235-04-2] (I)
1-Hexene [592-41-6] 50 ppm
sec-Hexyl acetate [108-84-9] 50 ppm
Hexylene glycol [107-41-5] C 25 ppm
Hexylene glycol, Inhalable, aerosol only [107-41-5] (I)
Hexylene glycol, vapour [107-41-5] (I)
Hydrazine [302-01-2] 0.01 ppm Skin; 2A
Hydrogen [1333-74-0] Simple EX
asphyxiant
Hydrogenated terphenyls - Nonirradiated [61788-32-7] 0.5 ppm
Hydrogen bromide [10035-10-6] Revised 2004 C 2 ppm
Hydrogen chloride [7647-01-0] Revised 2003 C 2 ppm
Hydrogen cyanide, as CN [74-90-8] C 4.7 ppm Skin
Cyanide salts, as CN [143-33-9; 151-50-8; 592-01-8] C 5 mg/m3 Skin
Hydrogen fluoride, as F [7664-39-3] C 2 ppm Skin
Hydrogen peroxide [7722-84-1] 1 ppm
Hydrogen selenide [7783-07-5] 0.05 ppm
Hydrogen sulfide [7783-06-4] C 10 ppm
Hydroquinone [123-31-9] Revised 2008 1 mg/m 3 S(D)
2-Hydroxypropyl acrylate [999-61-1] 0.5 ppm Skin; S(D)
Imazosulfuron [122548-33-8], Inhalable (I)
Indene [95-13-6] Revised 2008; 2010 10 ppm
Indium and compounds, as In [7440-74-6] 0.1 mg/m3 2A; 2B; (I)
Indium tin oxide, as In [50926-11-9] 2B, S(D); (I)
Iodine and iodides:
Iodides R; Skin; (I)
Iodides, as I [various], Inhalable R; Skin; (I)
Iodine [7553-56-2] Revised 2008; 2010 C 0.1 ppm R; Skin

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 11 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Iodine, as I [7553-56-2], Inhalable fraction and vapour R; Skin; (I)
Iodoform, as elemental Iodine [75-47-8] 0.6 ppm Skin; R
Iodoform, as elemental Iodine [75-47-8], Inhalable fraction and vapour Skin; R; (I)
Iron oxide dust, as Fe [1309-37-1] 5 mg/m3
Iron oxide fume , as Fe [1309-37-1] 5 mg/m3 10 mg/m3
Iron pentacarbonyl [13463-40-6] 0.01 ppm
Iron salts - soluble, as Fe 1 mg/m3 2 mg/m3
Isoamyl alcohol [123-51-3] 100 ppm 125 ppm
Isobutanol [78-83-1] 50 ppm
Isobutyl nitrite, Inhalable [542-56-3] C 1 ppm (V) 2B
Isobutyl nitrite, Total [542-56-3] 2B, (I)
Isoflurane [26675-46-7] R; (I)
Isooctyl alcohol [26952-21-6] 50 ppm Skin
Isophorone [78-59-1] C 5 ppm
Isophorone diisocyanate [4098-71-9] 0.005 ppm C 0.01 ppm S(R)
Isoprene [78-79-5] 2B
Isopropanol (Isopropyl alcohol, 2-Propanol) [67-63-0] Revised 2003 200 ppm 400 ppm
2-Isopropoxyethanol [109-59-1] 25 ppm Skin
Isopropylamine [75-31-0] 5 ppm 10 ppm Skin
N-Isopropylaniline [768-52-5] 2 ppm Skin
Isopropyl ether [108-20-3] 250 ppm 310 ppm
Isopropyl glycidyl ether (IGE) [4016-14-2] C 50 ppm
Kaolin, Respirable [1332-58-7] 2 mg/m3 (E)
Kerosene [8008-20-6; 64742-81-0]/Jet fuels, as total hydrocarbon vapour, 200 mg/m3 (P) Skin
Revised 2003
Ketene [463-51-4] 0.5 ppm 1.5 ppm
Lead - elemental and inorganic compounds, as Pb [7439-92-1] 0.05 mg/m 3 Elemental 2B; R
Other inorganic 2A;
R
Lead chromate, as Cr(VI), Total [7758-97-6] (See Hexavalent chromium A1, 1; S(D); S(R); R;
compounds, as Cr(VI), Total) (I)
Lead chromate, as Cr(VI), Inhalable [7758-97-6] A1, 1; S(D); S(R); R;
(I)
Lindane [58-89-9] 0.5 mg/m3 1; Skin
Liquified petroleum gas (L.P.G.) [68476-85-7] Revised 2020 Simple EX
asphyxiant
Lithium hydroxide [1310-65-2] C 1 mg/m3
Lithium hydride [7580-67-8] 0.025 mg/m 3

Magnesite [546-93-0] Revised 2006 (See Particles Not Otherwise Classified

(PNOC))
Magnesium oxide (fume), Inhalable [1309-48-4] Revised 2003 10 mg/m3
Magnesium oxide, Respirable dust and fume, as Mg [1309-48-4] 3 mg/m3 10 mg/m3
Malathion, Inhalable [121-75-5] Revised 2003 1 mg/m3 (V) 2A; Skin
Maleic anhydride [108-31-6] 0.1 ppm S(D); S(R)
Manganese - Elemental & inorganic compounds, as Mn, Total [7439-96-5] 0.2 mg/m3 R
Revised 2018
Manganese - Elemental & inorganic compounds, as Mn, Respirable [7439-96-5] 0.02 mg/m3 R
Revised 2018
Manganese - Elemental & inorganic compounds, as Mn, Inhalable R, (I)
[7439-96-5]
Manganese cyclopentadienyl tricarbonyl, as Mn [12079-65-1] 0.1 mg/m3 Skin
Melamine [108-78-1] 2B
Mercury - Alkyl compounds, as Hg [7439-97-6] 0.01 mg/m3 0.03 mg/m3 Skin; R

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 12 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Mercury - Aryl compounds, as Hg [7439-97-6] 0.05 mg/m3 C 0.1 mg/m3 Skin; R
Mercury - Elemental, as Hg [7439-97-6] 0.025 mg/m3 Skin; R
Mercury - Inorganic compounds, as Hg [7439-97-6] 0.025 mg/m3 Skin; R
Mercury – Methyl, as Hg [7439-97-6] 0.01 mg/m3 0.03 mg/m3 Skin; 2B, R
Mesityl oxide [141-79-7] 10 ppm 25 ppm
Methacrylic acid [79-41-4] 20 ppm
Methane [74-82-8] Revised 2018 Simple EX
asphyxiant
Methanol [67-56-1] 200 ppm 250 ppm Skin
Methomyl [16752-77-5] 2.5 mg/m3 Skin; R
Methoxychlor [72-43-5] 10 mg/m3
2-Methoxyethanol (EGME) [109-86-4] Revised 2006 0.1 ppm Skin; R
2-Methoxyethyl acetate (EGMEA) [110-49-6] Revised 2006 0.1 ppm Skin; R
Methoxyflurane [76-38-0] 2 ppm
4-Methoxyphenol [150-76-5] 5 mg/m3
1-Methoxy-2-propanol (PGME) [107-98-2] Revised 2018 50 ppm 100 ppm
2-Methoxy-1-propanol [1589-47-5] 20 ppm 40 ppm
1-Methoxypropyl-2-acetate [108-65-6] 50 ppm 75 ppm
2-Methoxypropyl-1-acetate [70657-70-4] 20 ppm 40 ppm
bis-(2-Methoxypropyl) ether (DPGME) (see Dipropylene glycol methyl ether)
[34590-94-8]
Methyl acetate [79-20-9] 200 ppm 250 ppm
Methyl acetylene [74-99-7] 1000 ppm EX
Methyl acetylene-propadiene mixture (MAPP) [59355-75-8] 1000 ppm 1250 ppm EX
Methyl acrylate [96-33-3] 2 ppm 2B; Skin; S(D)
Methylacrylonitrile [126-98-7] 1 ppm Skin
Methylal (see Dimethoxymethane) [109-87-5]
Methylamine [74-89-5] 5 ppm 15 ppm
Methyl n-amyl ketone [110-43-0] 50 ppm
N-Methylaniline [100-61-8] 0.5 ppm Skin
Methylarsonic acid [124-58-3] 2B
Methyl bromide [74-83-9] 1 ppm Skin
2-Methyl-2-butene [513-35-9] (I)
Methyl tert-butyl ether (MTBE) [1634-04-4] 50 ppm
Methyl n-butyl ketone [591-78-6] Revised 2008 5 ppm 10 ppm Skin; R
Methyl chloride [74-87-3] 50 ppm 100 ppm Skin; R
Methyl chloroform [71-55-6] 350 ppm 450 ppm
Methylcyclohexane [108-87-2] 400 ppm
Methylcyclohexanol [25639-42-3] 50 ppm
o-Methylcyclohexanone [583-60-8] 50 ppm 75 ppm Skin
Methylcyclohexanone, all isomers [591-24-2; 589-92-4; 1331-22-2] (I)
2-Methylcyclopentadienyl manganese tricarbonyl, as Mn [12108-13-3] 0.2 mg/m3 Skin
Methyl demeton, Inhalable [8022-00-2] Revised 2007 0.05 mg/m3 (V) Skin
Methylene bisphenyl isocyanate (MDI) [101-68-8] 0.005 ppm C 0.01 ppm S(R)
4,4'-Methylene bis(2-chloroaniline) (MBOCA; MOCA) [101-14-4] 0.01 ppm Skin; A2, 1
Revised 2009
Methylene bis (4-cyclohexylisocyanate) [5124-30-1] 0.005 ppm C 0.01 ppm S(R)
Methylene chloride (See Dichloromethane)
4,4'-Methylene dianiline [101-77-9] 0.01 ppm Skin; 2B
Methyl ethyl ketone (MEK) [78-93-3] 50 ppm 100 ppm R; Skin
Methyl ethyl ketone peroxide (MEKP) [1338-23-4] C 0.2 ppm
Methyleugenol [93-15-2] 2B
Methyl formate [107-31-3] Revised 2018 50 ppm 100 ppm Skin

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 13 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Methylhydrazine [60-34-4] 0.01 ppm Skin
4-Methylimidazole [693-98-1] 2B
Methyl iodide [74-88-4] 2 ppm Skin
Methyl isoamyl ketone [110-12-3] Revised 2018 20 ppm 50 ppm
Methyl isobutyl carbinol [108-11-2] Revised 2023 20 ppm 40 ppm
Methyl isobutyl ketone [108-10-1] Revised 2011 20 ppm 75 ppm 2B
Methyl isocyanate [624-83-9] Revised 2018 0.02 ppm 0.06 ppm Skin; S(D)
Methyl isopropyl ketone [563-80-4] Revised 2011 20 ppm R
Methyl mercaptan [74-93-1] 0.5 ppm
Methyl methacrylate [80-62-6] 50 ppm 100 ppm S(D)
1-Methylnaphthalene [90-12-0] Revised 2007 0.5 ppm Skin
2-Methylnaphthalene [91-57-6] Revised 2007 0.5 ppm Skin
Methylnapthalene, all isomers [90-12-0, 91-57-6, 1321-94-4] Skin; (I)
Methyl parathion [298-00-0] Revised 2009; 2010 0.2 mg/m3 Skin
Methyl propyl ketone (2-pentanone) [107-87-9] 150 ppm 250 ppm
Methyl silicate [681-84-5] 1 ppm
alpha-Methylstyrene [98-83-9] Revised 2015 10 ppm R; 2B
Methyltetrahydrophthalic anhydride isomers [3425-89-6; 5333-84-6; 11070-44-3; Skin; S(D); S(R); (I)
Methyl vinyl ketone [78-94-4] C 0.2 ppm
Metribuzin [21087-64-9] 5 mg/m 3

Mevinphos, Inhalable [7786-34-7] Revised 2003 0.01 mg/m3 (V) Skin

Mica, Respirable [12001-26-2] 3 mg/m3
Molybdenum - Metal and insoluble compounds, as Mo, Respirable 3 mg/m3
[7439-98-7]
Molybdenum - Metal and insoluble compounds, as Mo, Inhalable [7439-98-7] 10 mg/m3
Molybdenum - Soluble compounds, as Mo, Respirable [7439-98-7] 0.5 mg/m3
Molybdenum trioxide [1313-27-5] 2B
Monochloroacetic acid [79-11-8] See Chloroacetic acid
3-Monochloro-1,2-propanediol [96-24-2] 2B
Monocrotophos, Inhalable [6923-22-4] 0.05 mg/m3 (V) Skin
Monomethylformamide [123-39-7] Skin; (I)
Morpholine [110-91-8] 20 ppm Skin
beta-Myrcene [123-35-3] 2B
Naled, Inhalable [300-76-5] 0.1 mg/m3 (V) Skin; S(D)
Naphthalene [91-20-3] Revised 2018 10 ppm Skin; 2B
1,5-Naphthalene diisocyanate [3173-72-6] 0.005 ppm C 0.01 ppm
beta-Naphthylamine (2-Naphthylamine) [91-59-8] (L) A1, 1
Natural gas [8006-14-2] Revised 2018 Simple EX
asphyxiant
Natural rubber latex, as total proteins, Inhalable [9006-04-6] Revised 2004; 2008; 0.001 mg/m3 Skin; S(D); S(R)
2010
Neon [7440-01-9] Simple
asphyxiant
Nickel - Insoluble inorganic compounds, as Ni [7440-02-0] 0.05 mg/m3 A1, 1; (I)
Nickel - Elemental, Soluble inorganic compounds, as Ni [7440-02-0] 0.05 mg/m3 1, 2B; (I)
Nickel carbonyl, as Ni [13463-39-3] Revised 2018 0.001 ppm C 0.05 ppm 1; (I)
Nickel subsulfide, as Ni, Inhalable [12035-72-2] 0.1 mg/m3 A1, 1
Nicotine [54-11-5] 0.5 mg/m3 Skin
Nitrapyrin, Total [1929-82-4] 10 mg/m3 (N) 20 mg/m3
Nitrapyrin, Inhalable fraction and vapour [1929-82-4] (I)
Nitric acid [7697-37-2] 2 ppm 4 ppm
Nitric oxide [10102-43-9] 25 ppm

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 14 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

p-Nitroaniline [100-01-6] 3 mg/m3 Skin
2-Nitroanisole [91-23-6] 2A
3-Nitrobenzanthrone [17117-34-9] 2B
Nitrobenzene [98-95-3] 1 ppm Skin; 2B
p-Nitrochlorobenzene [100-00-5] 0.1 ppm 2B; Skin
4-Nitrodiphenyl [92-93-3] (L) Skin; A2
Nitroethane [79-24-3] 100 ppm
2-Nitrofluorene [607-57-8] 2B
Nitrogen [7727-37-9] Simple
asphyxiant
Nitrogen dioxide [10102-44-0] C 1 ppm
Nitrogen trifluoride [7783-54-2] 10 ppm
Nitroglycerin (NG) [55-63-0] 0.05 ppm Skin
Nitromethane [75-52-5] 20 ppm 2B
1-Nitropropane [108-03-2] 25 ppm
2-Nitropropane [79-46-9] 5 ppm 2B
Nitropyrene, mono, di, tri, tetra, isomers [42397-64-8; 42397-65-9; 5522-43-0; 2A; 2B; (I)
57835-92-4; 75321-20-9]
n-Nitrosodiethanolamine [1116-54-7] 2B
n-Nitrosodiethylamine [55-18-5] 2A
n-Nitrosodimethylamine [62-75-9] (L) Skin; 2A
n-Nitrosomethylethylamine [10595-95-6] 2B
n-Nitrosomethylvinylamine [4549-40-0] 2B
n-Nitrosomorpholine [59-89-2] 2B
n-Nitrosopiperidine [100-75-4] 2B
n-Nitrosopyrrolidine [930-55-2] 2B
Nitrotoluene, all isomers [88-72-2; 99-08-1; 99-99-0] 2 ppm Skin; 2A; (I)
5-Nitro-o-toluidine, Inhalable [99-55-8] Revised 2007 1 mg/m3
5-Nitro-o-toluidine, Inhalable fraction and vapour [99-55-8] (I)
Nitrous oxide [10024-97-2] 25 ppm R
Nonane [111-84-2] Revised 2015 200 ppm
Octachloronaphthalene [2234-13-1] 0.1 mg/m3 0.3 mg/m3 Skin
Octane, all isomers [111-65-9] 300 ppm
Oil mist - mineral, mildly refined 0.2 mg/m3 1
Oil mist - mineral, severely refined 1 mg/m3
Osmium tetroxide, as Os [20816-12-0] 0.0002 ppm 0.0006 ppm
Oxalic acid, anhydrous [144-62-7] and dihydrate [6153-56-6] Revised 2018 1 mg/m 3
2 mg/m3
p,p'-Oxybis(benzenesulfonyl hydrazide), Inhalable [80-51-3] Revised 2008 0.1 mg/m3 R
Oxygen difluoride [7783-41-7] C 0.05 ppm
Ozone - Heavy work [10028-15-6] 0.05 ppm
Ozone - Moderate work [10028-15-6] 0.08 ppm
Ozone - Light work [10028-15-6] 0.1 ppm
Ozone - Light, mod., or heavy workload =/< 2 hrs [10028-15-6] 0.2 ppm
Paraffin wax fume [8002-74-2] 2 mg/m3
Paraquat, as the cation, Respirable [4685-14-7] 0.1 mg/m3 Skin
Paraquat, as the cation, Total [4685-14-7] 0.5 mg/m3 Skin
Paraquat, as the cation, Inhalable [4685-14-7] Skin; (I)
Parathion, Inhalable [56-38-2] Revised 2003 3
0.05 mg/m (V) 2B; Skin
Particles (Insoluble or Poorly Soluble) Not Otherwise Classified (PNOC) 10 mg/m3 (N)
Pentaborane [19624-22-7] 0.005 ppm 0.015 ppm Skin
Pentachloronaphthalene [1321-64-8] 0.5 mg/m3 Skin
Pentachloronaphthalene, Inhalable fraction and vapour [1321-64-8] Skin, (I)

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 15 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Pentachloronitrobenzene [82-68-8] 0.5 mg/m3
Pentachlorophenol [87-86-5] 0.5 mg/m3 1; Skin
Pentaerythritol [115-77-5] 10 mg/m3 (N)
Pentane, all isomers [78-78-4; 109-66-0; 463-82-1] Revised 2018 1000 ppm
2,4-Pentanedione [123-54-6] Skin; (I)
Pentyl acetate, all isomers [123-92-2; 620-11-1; 624-41-9; 625-16-1; 626-38-0; 50 ppm 100 ppm
628-63-7]
Peracetic acid [79-21-0] (I)
Perchloroethylene (See Tetrachloroethylene)
Perchloromethyl mercaptan [594-42-3] 0.1 ppm
Perchloryl fluoride [7616-94-6] 3 ppm 6 ppm
Perfluorobutyl ethylene [19430-93-4] Revised 2004 100 ppm
Perfluoroisobutylene [382-21-8] C 0.01 ppm
Perlite [93763-70-3] Revised 2006 (See Particles Not Otherwise Classified
(PNOC))
Persulfates, as persulfate [7727-21-1; 7727-54-0; 7775-27-1] 0.1 mg/m3
Phenol [108-95-2] 5 ppm Skin
Phenolpththalein [77-09-8] 2B
Phenothiazine [92-84-2] 5 mg/m3 Skin; S(D)
Phenothiazine [92-84-2], Inhalable (I)
N-Phenyl-beta-naphthylamine [135-88-6] (L)
m-Phenylenediamine [108-45-2] 0.1 mg/m3
o-Phenylenediamine [95-54-5] 0.1 mg/m3 2B
p-Phenylenediamine [106-50-3] 0.1 mg/m3 S(D)
Phenyl ether - Vapour (Diphenyl ether) [101-84-8] 1 ppm 2 ppm
Phenylethyl alcohol [60-12-8] R; Skin; (I)
Phenyl glycidyl ether (PGE) [122-60-1] Revised 2008 0.1 ppm 2B; Skin; S(D); R
Phenylhydrazine [100-63-0] 0.1 ppm Skin
Phenyl isocyanate [103-71-9] 0.005 ppm 0.015 ppm Skin; S(D); S(R)
Phenyl mercaptan [108-98-5] C 0.1 ppm Skin
Phenylphosphine [638-21-1] C 0.05 ppm R
Phorate, Inhalable [298-02-2] Revised 2005 0.05 mg/m3 (V) Skin
Phosgene [75-44-5] 0.1 ppm
Phosphine [7803-51-2] 0.3 ppm 1 ppm
Phosphoric acid [7664-38-2] 1 mg/m3 3 mg/m3
Phosphorus (yellow) [12185-10-3] 0.1 mg/m3
Phosphorus oxychloride [10025-87-3] 0.1 ppm
Phosphorus pentachloride [10026-13-8] 0.1 ppm
Phosphorus pentasulfide [1314-80-3] 1 mg/m3 3 mg/m3
Phosphorus trichloride [7719-12-2] 0.2 ppm 0.5 ppm
o-Phthalaldehyde [643-79-8] Skin; S(D); S(R); (I)
Phthalic anhydride [85-44-9] 1 ppm S(D); S(R); Skin
Phthalic anhydride, Inhalable fraction and vapour [85-44-9] S(D); S(R); Skin (I)
m-Phthalodinitrile, Inhalable [626-17-5] Revised 2009 5 mg/m3 (V)
o-Phthalodinitrile [91-15-6] (I)
Picloram [1918-02-1] 3
10 mg/m (N)
Picric acid [88-89-1] 0.1 mg/m3 S(D)
Pindone [83-26-1] 0.1 mg/m3
Piperazine and its Salts, as Piperazine [110-85-0] 0.3 mg/m3 1 mg/m3 S(D); S(R)
Piperidine [110-89-4] 1 ppm
Plaster of Paris [26499-65-0] 10 mg/m3 (N) 20 mg/m3
Platinum - Metal [7440-06-4] 1 mg/m3

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 16 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Platinum - Soluble salts (as Pt) [7440-06-4] 0.002 mg/m3
Polyvinyl chloride (PVC), Respirable [9002-86-2] Revised 2008 1 mg/m3
Portland cement, Respirable [65997-15-1] Revised 2015 1 mg/m3 (E)
Potassium bromate [7758-01-2] 2B
Potassium hydroxide [1310-58-3] C 2 mg/m 3

Prometon [1610-18-0], Inhalable (I)

Prometryn [7287-19-6], Inhalable R; (I)
Propane [74-98-6] Revised 2018 Simple EX
asphyxiant
Propane sultone [1120-71-4] (L) 2A
n-Propanol (n-Propyl alcohol) [71-23-8] Revised 2007 100 ppm
2-Propanol [67-63-0] (see Isopropanol)
Propargyl alcohol [107-19-7] 1 ppm Skin
beta-Propiolactone [57-57-8] 0.5 ppm 2B
Propionaldehyde [123-38-6] 20 ppm
Propionic acid [79-09-4] 10 ppm
Propoxur [114-26-1] 0.5 mg/m3
Propyl acetate isomers [108-21-4; 109-60-4] 100 ppm 150 ppm
Propylene [115-07-1] Revised 2006 500 ppm
Propylene dichloride (1,2-Dichloropropane) [78-87-5] Revised 2006 75 ppm 110 ppm 1; S(D)
Propylene glycol dinitrate [6423-43-4] 0.05 ppm Skin
Propylene glycol ethyl ether [1569-02-4] Skin; (I)
Propylene oxide [75-56-9] 2 ppm 2B; S(D)
Propyleneimine (2-Methylaziridine) [75-55-8] Revised 2009; 2010 2 ppm 2B; Skin
n-Propyl nitrate [627-13-4] 25 ppm 40 ppm
Pyrethrum [8003-34-7] 5 mg/m 3

Pyridine [110-86-1] Revised 2004 1 ppm 2B

Resin acids, as Total resin acids [8050-09-7] S(D); S(R); (I)
Resorcinol [108-46-3] 10 ppm 20 ppm
Rhodium, Metal and insoluble compounds as Rh [7440-16-6] 0.1 mg/m3 0.3 mg/m3
Rhodium - Soluble compounds, as Rh [7440-16-6] 0.001 mg/m3 0.003 mg/m3
Ronnel, Inhalable [299-84-3] Revised 2006 5 mg/m3 (V)
Rosin core solder thermal decomposition products (colophony) (L) S(D); S(R)
[8050-09-7]
Rotenone (commercial) [83-79-4] 5 mg/m3
Rouge [1309-37-1] 10 mg/m3 (E,N)

Rubber solvent (Naphtha) [8030-30-6] Revised 2009 (H)

Safrole [94-59-7] 2B
Selenium and compounds, as Se [7782-49-2] 0.1 mg/m3
Selenium hexafluoride, as Se [7783-79-1] 0.05 ppm
Sesone [136-78-7] 10 mg/m3 (N)
Sevoflurane [28523-86-6] (I)
Silica, Amorphous - Diatomaceous earth (uncalcined), Total 4 mg/m 3

[61790-53-2]
Silica, Amorphous - Diatomaceous earth (uncalcined), Respirable 1.5 mg/m3
[61790-53-2]
Silica, Amorphous - Fume, Total [69012-64-2] 4 mg/m3
Silica, Amorphous - Fume, Respirable [69012-64-2] 1.5 mg/m3
Silica, Amorphous - Precipitated and gel, Total [112926-00-8] 4 mg/m3
Silica, Amorphous - Precipitated and gel, Respirable [112926-00-8] 1.5 mg/m3
Silica, Crystalline - alpha quartz [14808-60-7; 1317-95-9] and Cristobalite, 0.025 mg/m3 A2, 1
Respirable [14464-46-1] Revised 2006

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 17 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Silicon [7440-21-3] Revised 2006 (See Particles Not Otherwise Classified
(PNOC))
Silicon carbide Nonfibrous, Inhalable, [409-21-2] Revised 2003 10 mg/m3 (E)
Silicon carbide, Nonfibrous, Respirable, [409-21-2] Revised 2003 3 mg/m3 (E)
Silicon carbide, Fibrous (including whiskers) [409-21-2] Revised 2003 0.1 f/cc (F) A2; 2A
Silicon carbide, Nonfibrous particles (containing <0.1% crystalline silica), (I)
Inhalable [409-21-2]
Silicon carbide, Nonfibrous particles (containing <0.1% crystalline silica), (I)
Respirable [409-21-2]
Silicon tetrahydride (Silane) [7803-62-5] 0.5 ppm 1 ppm
Silver and Compounds, as Ag [7440-22-4] 0.01 mg/m3 0.03 mg/m3
Simazine [122-34-9] (I)
Soapstone (see Talc) Revised 2011
Sodium azide (as Sodium azide) [26628-22-8] C 0.29 mg/m3
Sodium azide (as Hydrazoic acid vapour) [26628-22-8] C 0.11 ppm
Sodium bisulfite [7631-90-5] 5 mg/m3
Sodium fluoroacetate [62-74-8] 0.05 mg/m3 Skin
Sodium hydroxide [1310-73-2] C 2 mg/m3
Sodium metabisulfite [7681-57-4] 5 mg/m3
Starch [9005-25-8] 10 mg/m3 (N)
Stearates, Inhalable [57-11-4; 557-04-0; 557-05-1; 822-16-2] 10 mg/m3 (J)
Stearates, Respirable [57-11-4; 557-04-0; 557-05-1; 822-16-2] 3 mg/m3 (J)
Stoddard solvent (mineral spirits) [8052-41-3] 290 mg/m3 580 mg/m3
Strontium chromate, as Cr, Total [7789-06-2] 0.0005 mg/m3 A1; S(D); S(R); (I)
Strychnine [57-24-9] 0.15 mg/m3
Styrene - monomer [100-42-5] Revised 2020 20 ppm 40 ppm 2A
Styrene oxide [96-09-3] 2A; S(D); Skin; (I)
Subtilisins, as crystalline active pure enzyme [1395-21-7; 9014-01-1] C 0.00006 S(R)
mg/m3
Sucrose [57-50-1] 10 mg/m3 (N)
Sulfometuron methyl [74222-97-2] 5 mg/m3
Sulfometuron methyl, Inhalable fraction and vapour [74222-97-2] (I)
Sulfotepp (TEDP), Inhalable [3689-24-5] Revised 2005 0.1 mg/m (V) 3 Skin
Sulfoxaflor [946578-00-3] R, (I)
Sulfur dioxide [7446-09-5] 2 ppm 5 ppm
Sulfur hexafluoride [2551-62-4] 1000 ppm
Sulfuric acid, Thoracic [7664-93-9] Revised 2004 0.2 mg/m3 (M) A2, 1
Sulfur monochloride [10025-67-9] C 1ppm
Sulfur pentafluoride [5714-22-7] C 0.01 ppm
Sulfur tetrafluoride [7783-60-0] C 0.1 ppm
Sulfuryl fluoride [2699-79-8] 5 ppm 10 ppm
Sulprofos [35400-43-2] Revised 2009; 2010 1 mg/m3 Skin
Synthetic Vitreous Fibres - Continuous filament glass fibres 1 f/cc (F)
Synthetic Vitreous Fibres - Continuous filament glass fibres, Inhalable 5 mg/m3
Synthetic Vitreous Fibres - Glass wool fibres 1 f/cc (F)
Synthetic Vitreous Fibres - Rock wool fibres 1 f/cc (F)
Synthetic Vitreous Fibres - Slag wool fibres 1 f/cc (F)
Synthetic Vitreous Fibres - Special purpose glass fibres 1 f/cc (F) 2B
Synthetic Vitreous Fibres - Refractory ceramic fibres 0.2 f/cc (F) A2, 2B
2,4,5-T (2,4,5-Trichlorophenoxyacetic acid) [93-76-5] 10 mg/m3
Talc - Containing no asbestos fibres, Respirable [14807-96-6] 2 mg/m3 (E)
Talc - Containing asbestos fibres [14807-96-6] 0.1 f/cc (K) A1, 1

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 18 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Tantalum - Metal [7440-25-7] 5 mg/m3
Tantalum oxide dusts, as Ta [1314-61-0] 5 mg/m3
Tellurium and compounds (NOS), as Te, excluding hydrogen telluride [13494-80- 0.1 mg/m3
9]
Tellurium hexafluoride [7783-80-4] 0.02 ppm
Temephos, Total [3383-96-8] 10 mg/m3 20 mg/m3 Skin
Terbufos, Inhalable [13071-79-9] 0.01 mg/m3 (V) Skin
Terepthalic acid [100-21-0] 10 mg/m3 (N)
Terphenyls (o-, m-, p-isomers) [26140-60-3] C 5 mg/m3
1,1,2,2-Tetrabromoethane, Inhalable [79-27-6] Revised 2006 0.1 ppm (V)
1,1,2,2-Tetrabromoethane, Total [79-27-6] (I)
1,1,1,2-Tetrachloro-2,2-difluoroethane [76-11-9] Revised 2008; 2010 500 ppm
1,1,2,2-Tetrachloro-1,2-difluoroethane [76-12-0] Revised 2008; 2010 200 ppm
1,1,1,2-Tetrachloroethane [630-20-6] 2B
1,1,2,2-Tetrachloroethane [79-34-5] 1 ppm Skin; 2B
Tetrachloroethylene (Perchloroethylene) [127-18-4] 25 ppm 100 ppm 2A
Tetrachloronaphthalene [1335-88-2] 2 mg/m 3

Tetrachlorovinphos, Inhalable [22248-79-9; 22350-76-1; 961-11-5] 2B; S(D); Skin; (I)

Tetraethyl lead, as Pb [78-00-2] 0.075 mg/m3 Skin
Tetraethyl pyrophosphate (TEPP), Inhalable [107-49-3] Revised 2007 0.01 mg/m (V) Skin
Tetrafluoroethylene [116-14-3] 2 ppm 2A
Tetrahydrofuran [109-99-9] Revised 2005 50 ppm 100 ppm 2B; Skin
Tetramethyl lead, as Pb [75-74-1] 0.075 mg/m3 Skin
Tetramethyl succinonitrile [3333-52-6] 0.5 ppm Skin
Tetranitromethane [509-14-8] 0.005 ppm 2B
Tetrakis (hydroxymethyl) phosphonium chloride [124-64-1] Revised 2005 2 mg/m3 S(D)
Tetrakis (hydroxymethyl) phosphonium sulfate [55566-30-8] Revised 2005 2 mg/m3 S(D)
Tetryl [479-45-8] 1.5 mg/m3
Thallium and soluble compounds, as Tl, Inhalable [7440-28-0] Revised 2011 0.02 mg/m3 Skin
Thiacloprid [111988-49-9] Skin; (I)
4,4'-Thiobis(6-tert-butyl-m-cresol), Inhalable [96-69-5] Revised 2011 1 mg/m3
Thiodicarb [59669-26-0] S(D); (I)
Thioglycolic acid [68-11-1] 1 ppm Skin; S(D)
Thioglycolic acid and salts [68-11-1] Skin; S(D); (I)
Thionyl chloride [7719-09-7] C 1ppm
Thiram [137-26-8] Revised 2008; 2010 1 mg/m 3 S(D)
Tin - Metal [7440-31-5] 2 mg/m3
Tin - Oxide and inorganic compounds, except tin hydride, as Sn 2 mg/m3
[7440-31-5]
Tin - Organic compounds, as Sn [7440-31-5] 0.1 mg/m3 0.2 mg/m3 Skin
Titanium dioxide [13463-67-7] Revised 2006 10 mg/m3 (N) 2B
Titanium dioxide [13463-67-7]:
Nanoscale particles, Respirable (I)
Finescale particles, Respirable (I)
Titanium tetrachloride, as HCl [7550-45-0] (I)
o-Tolidine [119-93-7] Skin; 2B
Toluene [108-88-3] Revised 2007; 2008 20 ppm R
Toluene-2,4-diisocyanate (2,4-TDI) [584-84-9] 0.005 ppm C 0.01 ppm 2B; S(D); S(R); Skin
Toluene-2,6-diisocyanate (2,6-TDI) [91-08-7] 0.005 ppm C 0.01 ppm 2B; S(D); S(R); Skin
2,4- and 2,6- Toluene diisocyanate as a mixture [584-84-9; 91-08-7] 2B; S(D); S(R); Skin;
(I)
m-Toluidine [108-44-1] 2 ppm Skin

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 19 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

o-Toluidine [95-53-4] Revised 2009 2 ppm Skin; 1
p-Toluidine [106-49-0] 2 ppm Skin
Tributyl phosphate [126-73-8] 0.2 ppm
Trichloroacetic acid [76-03-9] Revised 2018 0.5 ppm 2B
Trichlorfon, Inhalable fraction and vapour [52-68-6] (see also trichlorphon) S(D); (I)
1,2,4-Trichlorobenzene [120-82-1] C 5 ppm
1,1,2-Trichloroethane [79-00-5] 10 ppm Skin
Trichloroethylene [79-01-6] Revised 2007 10 ppm 25 ppm A2, 1
Trichlorofluoromethane [75-69-4] C 1000 ppm
Trichloronaphthalene [1321-65-9] 5 mg/m3 Skin
2,4,6-Trichlorophenol [88-06-2] 2B
1,2,3-Trichloropropane [96-18-4] 10 ppm A2, 2A
1,1,2-Trichloro-1,2,2-trifluoroethane [76-13-1] 500 ppm 1250 ppm
Trichlorphon, Inhalable [52-68-6] Revised 2003 1 mg/m 3 S(D)
Triclosan [3380-34-5] Skin; (I)
Triethanolamine [102-71-6] 5 mg/m3
Triethylamine [121-44-8] Revised 2018 0.5 ppm 1 ppm Skin
Triflumizole, Inhalable [68694-11-1] S(D); (I)
Trifluorobromomethane [75-63-8] 1000 ppm
1,3,5-Triglycidyl-s-triazinetrione [2451-62-9] 0.05 mg/m3 R
Trimellitic anhydride [552-30-7] Revised 2008; 2010 C 0.04 mg/m3 Skin; S(D); S(R)
Trimethylamine [75-50-3] 5 ppm 15 ppm
Trimethyl benzene (mixed isomers) [25551-13-7; 526-73-8; 95-63-6; 108-67-8] 25 ppm
Trimethyl hexamethylene diisocyanate [28679-16-5] 0.005 ppm C 0.01 ppm
Trimethyl phosphite [121-45-9] 2 ppm
Tri-n-Butyltin compounds [688-73-3] 0.05 mg/m3
2,4,6-Trinitrotoluene (TNT), Total [118-96-7] 0.1 mg/m3 Skin
2,4,6-Trinitrotoluene (TNT), Inhalable fraction and vapour [118-96-7] Skin, (I)
Triorthocresyl phosphate [78-30-8] 0.1 mg/m3 Skin
Triphenyl phosphate [115-86-6] 3 mg/m3
Tris(2,3-dibromopropyl) phosphate [126-72-7] 2A
Tungsten and compounds in the absence of Cobalt, as W [7440-33-7] 3 mg/m 3

Turpentine [8006-64-2] and selected monoterpenes [80-56-8; 20 ppm S(D)

127-91-3; 13466-78-9] Revised 2003
Uranium (Natural) - Insoluble compounds, as U [7440-61-1] 0.2 mg/m3 0.6 mg/m3 A1, 1; (I)
Uranium (Natural) - Soluble compounds, as U [7440-61-1] 0.05 mg/m3 A1, 1; (I)
n-Valeraldehyde [110-62-3] 50 ppm
Vanadium pentoxide, as V, Inhalable [1314-62-1] Revised 2015 0.05 mg/m3 2B
Vegetable oil, Mist, Respirable, except castor, cashew nut, or similar irritating oil 3 mg/m3
[8008-89-7]
Vinyl acetate [108-05-4] 10 ppm 15 ppm 2B
Vinyl bromide [593-60-2] 0.5 ppm A2, 2A
Vinyl chloride [75-01-4] 1 ppm A1, 1
4-Vinyl cyclohexene [100-40-3] 0.1 ppm 2B; R
Vinyl cyclohexene dioxide [106-87-6] 0.1 ppm Skin; 2B; R
Vinyl fluoride [75-02-5] 1 ppm A2, 2A
N-Vinyl-2-pyrrolidone [88-12-0] Revised 2003 0.05 ppm
Vinylidene chloride [75-35-4] 1 ppm 2B
Vinylidene fluoride [75-38-7] 500 ppm
Vinyl toluene, all isomers [25013-15-4] 25 ppm 75 ppm
Vinyltoluene, all isomers [25013-15-4; 611-15-4;100-80-1; 622-97-9] (I)
VM & P Naphtha [8032-32-4] Revised 2009 (H)

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 20 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] TWA STEL/Ceiling Notations

Warfarin [81-81-2] 0.1 mg/m3 R; Skin
Wood dust - Allergenic species 1 mg/m3 S(R); S(D); A1, A2,
1; (I)
Wood dust - Non-Allergenic Hardwood 1 mg/m3 A1, A2, 1; (I)
Wood dust - Non-Allergenic Softwood 2.5 mg/m3 1; (I)
Xylene [1330-20-7] (o, m & p isomers) [95-47-6; 108-38-3; 106-42-3] 100 ppm 150 ppm
m-Xylene alpha,alpha'-diamine [1477-55-0] C 0.1 mg/m3 Skin
Xylidine - Mixed isomers, Inhalable [1300-73-8] 0.5 ppm (V) Skin
Yttrium - Metal [7440-65-5] 1 mg/m3
Yttrium and compounds, as Y [7440-65-5] 1 mg/m3
Zinc chloride - Fume [7646-85-7] 1 mg/m3 2 mg/m3
Zinc chromates, as Cr, Total [13530-65-9; 11103-86-9; 37300-23-5] 0.01 mg/m 3 A1, 1; S(D); S(R); (I)
Zinc oxide, Respirable [1314-13-2] Revised 2003 2 mg/m3 10 mg/m3
Zirconium and compounds, as Zr [7440-67-7] 5 mg/m3 10 mg/m3

Endnotes
(E) - the value is for particulate matter containing no asbestos and less than 1% crystalline silica.
(F) - the value for fibres longer than 5 microns, with an aspect ratio of equal than/greater than 3:1, as determined by the membrane filter method at
400-450 times magnification (4 mm objective), using phase-contrast illumination.
(G) - as measured by the vertical elutriator, cotton-dust sampler, see TLV Documentation.
(H) - reciprocal calculation method, see OHS Guideline G5.48-12.
(I) - see Special Notes in Table 1 below.
(J) - does not include stearates of toxic metals.
(K) - should not exceed 2 mg/m3 respirable particulate.
(L) - No exposure limit. Exposure by all routes should be carefully controlled to levels as low as possible.
(M) - refers to sulfuric acid contained in strong inorganic acid mists.
(N) - the 8-hour TWA listed in the Table is for the total dust. The substance also has an 8-hour TWA of 3 mg/m3 for the respirable fraction.
(O) - sampled by method that does not collect vapour.
(P) - application restricted to conditions in which there are negligible aerosol exposures.
(V) - vapour and inhalable aerosol.

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 21 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Table 1: Special Notes

Substance [CAS No.] Note
Asphalt (Bitumen) fume, as benzene-soluble aerosol, Inhalable IARC group 2A carcinogen - Bitumens, occupational
[8052-42-4] exposure to oxidized bitumens and their emissions
Beryllium and compounds, as Be [7440-41-7] Soluble compounds - dermal sensitization
Soluble and insoluble compounds - respiratory
2,4-Dichlorophenoxyacetic acid and its esters [94-75-7] IARCi igroup
i 2B carcinogens - chlorophenoxy
herbicides as a group
Diesel fuel, as total hydrocarbons, Inhalable
[68334-30-5; 68476-30-2; 68476-31-3; 68476-34-6; 77650-28-3] Diesel fuel, marine, is an IARC group 2B carcinogen

Dinitrotoluene [25321-14-6] Dinitrotoluene

p p are IARC groupg2B carcinogens
p g
Indium and compounds, as In [7440-74-6] Indium tin oxide is an IARC group 2B carcinogen
Hexane (Commercial, <54% n-Hexane) and the branched hexane isomers Skin notation only applies to Hexane (Commercial,
[various, including 64742-49-0; 64742-89-8; 75-83-2; 79-29-8; 96-14-0; 107-83-5] <54% n-Hexane). Skin notation does not apply to
branched hexane isomers.
g p g ( ) p
Lead chromate, as Cr [7758-97-6] as a whole y g
Nickel - Elemental, Soluble inorganic compounds, as Ni [7440-02-0] group 2B carcinogens. Nickel compounds are IARC
Nickel - Insoluble inorganic compounds, as Ni [7440-02-0]
Nickel compounds are IARC group 1 carcinogens
Nickel carbonyl, as Ni [13463-39-3]
Nitropyrene, mono, di, tri, tetra, isomers [42397-64-8; 42397-65-9; 5522-43-0; 1-Nitropyrene is an IARC group 2A carcinogen
57835-92-4; 75321-20-9] 4-Nitropyrene is an IARC group 2B carcinogen
1,6-Dinitropyrene is an IARC 2B carcinogen
1,8-Dinitropyrene is an IARC 2B carcinogen
1,3-Dinitropyrene is an IARC 2B carcinogen
Nitrotoluene, all isomers [88-72-2; 99-08-1; 99-99-0] 2-Nitrotoluene [88-72-2] is an IARC 2A carcinogen
Strontium chromate, as Cr, Total [7789-06-2] Strontium chromate is a hexavalent chromium
compound
Uranium (Natural) [7440-61-1] Ionizing radiation (all types) and Radionuclides are
IARC group 1 carcinogens
Wood dust ACGIH sensitizer - western red cedar
ACGIH A1 - oak and beech
ACGIH A2 - birch, mahogany, teak, walnut
Wood dust is an IARC group 1 carcinogen.
Zinc chromates, as Cr [13530-65-9; 11103 -86-9; 37300-23-5] Zinc chromate is a hexavalent chromium compound

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 22 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] Note

Acetamide [60-35-5] No British Columbia exposure limit at this time.
Acetamiprid, Inhalable fraction and vapour [135410-20-7]
Aldicarb [116-06-3]
Allyl bromide [106-95-6]
Allyl methacrylate [96-05-9]
Antimony trioxide, Inhalable [1309-64-4]
Bendiocarb [22781-23-3]
Bensulide, Inhalable fraction and vapour [741-58-2]
Benzoic acid and alkali benzoates:
Benzoic acid [65-85-0], Inhalable fraction and vapour
Sodium benzoate, as benzoate [532-32-1], Inhalable
Potassium benzoate, as benzoate [582-25-2], Inhalable
Boron trichloride [10294-34-5]
Buprofezin, Inhalable fraction and vapour [69327-76-0]
Butenes, all isomers, including Isobutene [106-98-9; 107-01-7;
590-18-1; 624-64-6; 25167-67-3; 115-11-7]
4-tert-Butylbenzoic acid [98-73-7]
tert-Butyl hydroperoxide [75-91-2]
Cadusafos [95465-99-9]
Captafol, Inhalable fraction and vapour [2425-06-1]
Carfentrazone-ethyl [128639-02-1]
Chlordane, Inhalable fraction and vapour [57-74-9]
Chromium - Metallic, as Cr(0) [7440-47-3], Inhalable
Chromium - trivalent chromium compounds, as Cr(III), Inhalable [7440-47-3]
Chromium - hexavalent chromium compounds, as Cr(VI), Inhalable [7440-47-3]
Citral, inhalable [5292-40-5]
Clothianidin [210880-92-5], Inhalable
Cobalt and inorganic compounds, as Co, Inhalable [7440-48-4]
Cyanazine [21725-46-2]
Cyanogen bromide [506-68-3]
Cyromazine [66215-27-8], Inhalable
Diethylene glycol monobutyl ether [112-34-5]
N,N-Diethylhydroxylamine [3710-84-7]
Dimethylphenol, all isomers [95-65-8; 95-87-4; 105-67-9; 108-68-9; 526-75-0; 576-
26-1; 1300-71-6]
Divinylbenzene-ethyl styrene mixtures, as total divinylbenzene isomers [69011-19-
4; 7525-62-4; 108-57-6; 105-06-6]
EPN, Inhalable fraction and vapour [2104-64-5]
Ethylene glycol - Inhalable, aerosol only [107-21-1]
Ethylene glycol dimethyl ether [110-71-4]
2-Ethyl-1-hexanol [104-76-7]
Fenoxycarb, Inhalable [72490-01-8]
Fentanyl [437-38-7] and Fentanyl Citrate, as Fentanyl, Inhalable [990-73-8]
Fludioxonil [131341-86-1]
Fluorine, as F [7782-41-4]
Folpet [133-07-3]
Glycidyl methacrylate [106-91-2]
Glyphosate, Inhalable [1071-83-6]
Hexamethylenetetramine, Inhalable fraction and vapour [100-97-0]
Hexane (Commercial, <54% n-Hexane) and the branched hexane isomers
[various, including 64742-49-0; 64742-89-8; 75-83-2; 79-29-8; 96-14-0; 107-83-5]

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 23 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] Note

Hexazinone [51235-04-2]
Hexylene glycol, Inhalable, aerosol only [107-41-5]
Hexylene glycol, vapour [107-41-5]
Imazosulfuron [122548-33-8], Inhalable
Indium tin oxide, as In [50926-11-9]
Iodides
Iodides, as I, Inhalable
Iodine, as I, Inhalable draftion and vapour [7553-56-2]
Iodoform, as elemental Iodine [75-47-8], Inhalable fraction and vapour
Isobutyl nitrite, Total [542-56-3]
Isoflurane [26675-46-7]
Lead chromate, as Cr(VI), Inhalable [7758-97-6]
Manganese, elemental and inorganic compounds, as Mn, Inhalable
[7439-96-5]
2-Methyl-2-butene [513-35-9]
Methylcyclohexanone, all isomers [591-24-2; 589-92-4; 1331-22-2]
Methylnaphthalene, all isomers [90-12-0; 91-57-6; 1321-94-4]
Methyltetrahydrophthalic anhydride isomers [3425-89-6; 5333-84-6; 11070-44-3;
19438-64-3; 26590-20-5; 42498-58-8]
Monomethylformamide [123-39-7]
Nitrapyrin, Inhalable fraction and vapour [1929-82-4]
5-Nitro-o-toluidine, Inhalable fraction and vapour [99-55-8]
Paraquat, as the cation, Inhalable [4685-14-7]
2,4-Pentanedione [123-54-6]
Pentachloronaphthalene, Inhalable fraction and vapour [1321-64-8]
Peracetic acid [79-21-0]
Phenothiazine, Inhalable [92-84-2]
Phenylethyl alcohol [60-12-8]
o-Phthalaldehyde [643-79-8]
Phthalic anhydride, Inhalable fraction and vapour [85-44-9]
o-Phthalodinitrile [91-15-6]
Prometon [1610-18-0], Inhalable
Prometryn [7287-19-6], Inhalable
Propyl acetate isomers, as a mixture [108-21-4; 109-60-4]
Propylene glycol ethyl ether [1569-02-4]
Resin acids, as Total resin acids [8050-09-7]
Sevoflurane [28523-86-6]
Silicon carbide, Nonfibrous particles (containing <0.1% crystalline silica),
Inhalable [409-21-2]
Silicon carbide, Nonfibrous particles (containing <0.1% crystalline silica),
Respirable [409-21-2]
Simazine [122-34-9]
Styrene oxide [96-09-3]
Sulfometuron methyl, Inhalable fraction and vapour [74222-97-2]
Sulfoxaflor [946578-00-3]
1,1,2,2-Tetrabromoethane, Total [79-27-6]
Tetrachlorvinphos, Inhalable [22248-79-9; 22350-76-1; 961-11-5]
Thiacloprid [111988-49-9]
Thiodicarb [59669-26-0]
Thioglycolic acid and salts [68-11-1]
Titanium dioxide [13463-67-7], Nanoscale particles and finescale particles,
Respirable
Titanium tetrachloride, as HCl [7550-45-0]

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 24 of 25
Table of exposure limits for chemical and biological substances Updated 2024/04/11

Substance [CAS No.] Note

2,4- and 2,6- Toluene diisocyanate as a mixture [584-84-9; 91-08-7] (see OHS
Regulation s. 5.51)
Trichlorfon, Inhalable fraction and vapour [52-68-6]
Triclosan [3380-34-5]
Triflumizole, Inhalable [68694-11-1]
2,4,6-Trinitrotoluene (TNT), Inhalable fraction and vapour [118-96-7]
Vinyltoluene, all isomers [611-15-4; 100-80-1; 622-97-9; 25013-15-4]

Bracketed letters are end notes, e.g., "(L)" and "(V)";

STEL column C = Ceiling limit;
Notations column R = Adverse reproductive effect; S = Sensitizer;
A1, A2, 1, 2A, 2B = Carcinogen designations Page 25 of 25